Facing the Reality of a Chronic Condition Persistent or chronic ITP is a lifelong condition, which means you may always need medications and other treatments to manage your symptoms. And you’ll ...

Stimulating platelet production with romiplostim is an effective strategy for managing patients with ITP. Thrombocytopenias can be caused by increased platelet destruction, decreased platelet ...

Conclusion: Romiplostim is a novel thrombopoietic-stimulating agent for use in patients with chronic ITP who have not responded to other therapies.

LUND, SWEDEN / ACCESS Newswire / April 8, 2025 /BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV), a biotech ...

TAVALISSE (fostamatinib disodium hexahydrate) tablets is indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient ...

New Delhi: Zydus Lifesciences has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...